$INJ-USD

Analyst Ali Martinez identified XRP, Quant (QNT), and Injective (INJ) as altcoins with potential breakouts. XRP is near a key support level of $1.50, Quant is testing $262, and Injective is near $7.33. Their future performance depends on defending these levels and continued market recovery.

Injective (INJ) rose 3.25% in 27 hours due to its launch on Solana, regulatory clarity from the SEC, and institutional signals. The token's integration into major Solana platforms and reduced legal risks boosted its appeal. Strong on-chain activity and a positive altcoin market also supported the price increase.

Injective Protocol (INJ) integrated its token across Solana, making it available on platforms like Meteora, Raydium, and Phantom. INJ is the native token of the decentralized exchange protocol, used for governance and staking. Injective offers cross-chain trading and gas-free transactions.

Injective and Solana launched a bridge enabling INJ transfers between the networks. The connection allows INJ holders to access each other's ecosystems for trading and DeFi activities. The impact depends on actual transfer volumes, with no changes to Solana's protocol.

Injective (INJ) surged 10.47% in 24 hours, driven by integration with Solana, new liquidity venues, and upcoming upgrades. INJ is now tradable on Raydium and supported by Phantom wallet. Circle's USDC migration and ETF filings also contributed to the rally. INJ's volume increased 50.61%, outperforming a flat crypto market.

21Shares filed an amended S-1 with the SEC to list a spot Injective ETF (TINJ) on Nasdaq, tracking the INJ token's price. The ETF, sponsored by 21Shares, will hold INJ through Coinbase and BitGo, with FTSE setting the benchmark. Approval from the SEC and Nasdaq is still required.

Injective (INJ) surged 17-18% in 24 hours due to its native launch on Solana and progress on a US-listed ETF. The token is now live on Solana with integrations across major DeFi platforms. The ETF, targeting a Nasdaq listing under 'TINJ,' aims to stake 40-60% of its INJ holdings. Trading volume spiked 181% to $226.6 million.

Injective (INJ) surged 3.87% in 15 hours due to its integration with Solana, allowing trading on Solana-based platforms like Raydium. The move was driven by increased attention, trading routes, and perceived demand, with social media amplifying the news. According to reports, INJ is now live on multiple Solana DeFi and memecoin venues, expanding its user base and liquidity.

Injective Protocol, a decentralized exchange built on Cosmos SDK, has been integrated with Solana. Users can now trade INJ against SOL and other SPL tokens 24/7, according to the company. Injective offers cross-chain trading, decentralization, and gas-free transactions.

The article says Bitcoin’s BIP-110 soft fork failed, getting only 2.5% support and splitting into a minority chain that mined two blocks before stalling. It also reports the CLARITY Act procedural vote was scheduled for September 15. It cites spot Bitcoin ETF inflows of $853.54M and mentions BTC at $64,814 and ETH at $1,908.